These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 2263673

  • 1. Effect of dopamine beta-hydroxylase inhibition on systemic hemodynamics in conscious, spontaneously hypertensive rats.
    Gellai M, DeWolf RE, Ruffolo RR.
    Pharmacology; 1990; 41(2):82-90. PubMed ID: 2263673
    [Abstract] [Full Text] [Related]

  • 2. Effect of the dopamine beta-hydroxylase inhibitor, SK&F 102698, on blood pressure in the 1-kidney, 1-clip hypertensive dog.
    Brooks DP, Fredrickson TA, Koster PF, Ruffolo RR.
    Pharmacology; 1991; 43(2):90-5. PubMed ID: 1775514
    [Abstract] [Full Text] [Related]

  • 3. Cardiovascular effects of a new potent dopamine beta-hydroxylase inhibitor in spontaneously hypertensive rats.
    Ohlstein EH, Kruse LI, Ezekiel M, Sherman SS, Erickson R, DeWolf WE, Berkowitz BA.
    J Pharmacol Exp Ther; 1987 May; 241(2):554-9. PubMed ID: 3572812
    [Abstract] [Full Text] [Related]

  • 4. Further characterization of the cardiovascular effects of the dopamine beta-hydroxylase inhibitor SK&F 102698 in conscious hypertensive rats.
    Ohlstein EH, Kruse LI, Ezekiel M, Willette RN.
    J Pharmacol Exp Ther; 1988 Oct; 247(1):186-95. PubMed ID: 3050029
    [Abstract] [Full Text] [Related]

  • 5. Effects of the novel dopamine beta-hydroxylase inhibitor SK&F 102698 on catecholamines and blood pressure in spontaneously hypertensive rats.
    Berkowitz BA, Arleth AJ, Sung CP, Kruse LI, DeWolf WE, Ohlstein EH.
    J Pharmacol Exp Ther; 1988 Jun; 245(3):850-7. PubMed ID: 3385645
    [Abstract] [Full Text] [Related]

  • 6. Hemodynamic effects of two ergot derivatives in the conscious spontaneously hypertensive rat.
    Susić D, Djordjević N, Kentera D.
    Pharmacology; 1984 Jun; 29(4):215-23. PubMed ID: 6494233
    [Abstract] [Full Text] [Related]

  • 7. Sustained high blood pressure reduction with etamicastat, a peripheral selective dopamine β-hydroxylase inhibitor.
    Igreja B, Wright LC, Soares-da-Silva P.
    J Am Soc Hypertens; 2016 Mar; 10(3):207-16. PubMed ID: 26803288
    [Abstract] [Full Text] [Related]

  • 8. Blood pressure decrease in spontaneously hypertensive rats folowing renal denervation or dopamine β-hydroxylase inhibition with etamicastat.
    Pires NM, Igreja B, Moura E, Wright LC, Serrão MP, Soares-da-Silva P.
    Hypertens Res; 2015 Sep; 38(9):605-12. PubMed ID: 25854989
    [Abstract] [Full Text] [Related]

  • 9. Systemic and regional hemodynamic effects of acute and prolonged treatment with urapidil or prazosin in normotensive and spontaneously hypertensive rats.
    Pegram BL, Kobrin I, Natsume T, Gallo AJ, Frohlich ED.
    Am J Med; 1984 Oct 05; 77(4A):64-73. PubMed ID: 6486158
    [Abstract] [Full Text] [Related]

  • 10. Hemodynamic effects of mebutamate in spontaneously hypertensive rats.
    Pfeffer JM, Pfeffer MA, Frohlich ED.
    Arch Int Pharmacodyn Ther; 1975 May 05; 215(1):133-8. PubMed ID: 1156042
    [Abstract] [Full Text] [Related]

  • 11. Systemic and regional hemodynamic effect of acute magnesium administration in the normotensive and hypertensive state.
    DiPette DJ, Simpson K, Guntupalli J.
    Magnesium; 1987 May 05; 6(3):136-49. PubMed ID: 3626625
    [Abstract] [Full Text] [Related]

  • 12. Cardiac output and peripheral vascular resistance during intravenous infusion of 1-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine in conscious normotensive and spontaneously hypertensive rats.
    Hubbard JW, Cox RH, Lawler JE, Blank ML, Snyder F.
    Res Commun Chem Pathol Pharmacol; 1985 Sep 05; 49(3):459-62. PubMed ID: 4059660
    [Abstract] [Full Text] [Related]

  • 13. Relaxin increases cardiac output and reduces systemic arterial load in hypertensive rats.
    Debrah DO, Conrad KP, Jeyabalan A, Danielson LA, Shroff SG.
    Hypertension; 2005 Oct 05; 46(4):745-50. PubMed ID: 16172427
    [Abstract] [Full Text] [Related]

  • 14. Role of beta 2-receptor stimulation in the peripheral vascular actions of the antihypertensive dilevalol.
    Watkins RW, Sybertz EJ, Cook J, Pula K, Cedeno K, Tedesco RP, McLeod R.
    Arch Int Pharmacodyn Ther; 1989 Oct 05; 302():158-73. PubMed ID: 2576892
    [Abstract] [Full Text] [Related]

  • 15. Atrial extract: hemodynamics in Wistar-Kyoto and spontaneously hypertensive rats.
    Pegram BL, Kardon MB, Trippodo NC, Cole FE, MacPhee AA.
    Am J Physiol; 1985 Aug 05; 249(2 Pt 2):H265-71. PubMed ID: 3161345
    [Abstract] [Full Text] [Related]

  • 16. Role of beta1-3-adrenoceptors in blood pressure control at rest and during tyramine-induced norepinephrine release in spontaneously hypertensive rats.
    Berg T, Piercey BW, Jensen J.
    Hypertension; 2010 May 05; 55(5):1224-30. PubMed ID: 20231523
    [Abstract] [Full Text] [Related]

  • 17. Hemodynamic profile of a new antihypertensive agent D,L-3-[2-(3-t-butylamino-2-hydroxypropoxy)phenyl]-6-hydrazinopyridazine (SK&F 92657).
    Taylor EM, Cameron D, Eden RJ, Fielden R, Owen DA.
    J Cardiovasc Pharmacol; 1981 May 05; 3(2):337-54. PubMed ID: 6166805
    [Abstract] [Full Text] [Related]

  • 18. Systemic and regional hemodynamic effects of E614 (tripamide) as studied in conscious SHR.
    Nakai M, Matsui Y, Yamamoto J.
    Arch Int Pharmacodyn Ther; 1986 Feb 05; 279(2):291-303. PubMed ID: 3963940
    [Abstract] [Full Text] [Related]

  • 19. Characterization of the antihypertensive activity of SK&F 86466, a selective alpha-2 antagonist, in the rat.
    Roesler JM, McCafferty JP, DeMarinis RM, Matthews WD, Hieble JP.
    J Pharmacol Exp Ther; 1986 Jan 05; 236(1):1-7. PubMed ID: 2867209
    [Abstract] [Full Text] [Related]

  • 20. Pharmacology of nebivolol.
    Janssens WJ.
    J Pharm Belg; 1992 Jan 05; 47(4):323-7. PubMed ID: 1357130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.